XML 16 R7.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Operating activities:    
Net (loss) income $ (495,851) $ 339,995
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:    
Depreciation and amortization 12,679 9,405
Reduction in carrying amount of right-of-use assets 6,228 6,438
Credit losses and sales allowances 262 752
Deferred taxes (419,965) (425,986)
Release of liabilities for unrecognized tax benefits (73) (162)
Share-based compensation expense 57,789 49,855
Digital asset impairment losses 783,807 76,613
Amortization of issuance costs on long-term debt 10,231 6,599
Loss (gain) on debt extinguishment 22,933 (44,686)
Changes in operating assets and liabilities:    
Accounts receivable 27,374 6,627
Prepaid expenses and other current assets 4,868 (99)
Deposits and other assets (6,748) (321)
Accounts payable and accrued expenses (8,318) (8,005)
Accrued compensation and employee benefits (26,383) (15,186)
Accrued interest 4,444 7,539
Deferred revenue and advance payments 3,484 9,901
Operating lease liabilities (7,832) (7,954)
Other long-term liabilities (4,637) 203
Net cash (used in) provided by operating activities (35,708) 11,528
Investing activities:    
Purchases of digital assets (4,008,210) (687,959)
Purchases of property and equipment (2,694) (2,591)
Net cash used in investing activities (4,010,904) (690,550)
Financing activities:    
Proceeds from convertible senior notes 3,213,750 0
Payments to settle conversions and redemption of convertible senior notes (398) 0
Repayments of secured debt and third-party extinguishment costs (515,325) (160,033)
Principal payments of other long-term secured debt (401) (382)
Proceeds from sale of common stock under public offerings 1,246,478 823,945
Issuance costs paid related to sale of common stock under public offerings (4,185) (4,286)
Proceeds from exercise of stock options 157,541 14,217
Payment of withholding tax on vesting of restricted stock units (2,173) (1,391)
Net cash provided by financing activities 4,046,067 676,025
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash 77 (997)
Net decrease in cash, cash equivalents, and restricted cash (468) (3,994)
Cash, cash equivalents, and restricted cash, beginning of period 48,673 50,868
Cash, cash equivalents, and restricted cash, end of period 48,205 46,874
Convertible Senior Notes    
Financing activities:    
Issuance costs paid for convertible senior notes (53,524) 0
Employee Stock Purchase Plan    
Financing activities:    
Proceeds from sales under employee stock purchase plan $ 4,304 $ 3,955